ERGi-USU-6 mesylate
ERGi-USU-6 (mesylate) is a selective salt-form inhibitor of ERG-positive prostate cancer, exhibiting potent activity with an IC50 of 89 nM. This small molecule is a valuable research tool for in vitro studies targeting ERG-driven oncogenic pathways and for probing disease mechanisms in relevant cellular models.
Product Specifications
Molecular Formula
C14H18N4O4S
Molecular Weight
338.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog